Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs International Business Machines Corp (IBM) Price & Performance

Edgewise Therapeutics Inc. Common StockTrade
International Business Machines CorpTrade

Price performance (Past 24H)

Key statistics

Edgewise Therapeutics Inc. Common Stock vs International Business Machines Corp — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while International Business Machines Corp trades at $227.24 (market cap $217.43B). The key difference: International Business Machines Corp is far larger — about 55.2× Edgewise Therapeutics Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.93% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and International Business Machines Corp for 89 Days on average.

EWTXIBM
Market Cap
$3.94B$217.43B
Volume
810,1045,119,486
Sector
HealthTechnology
52-Week High
$48.35$329.23
52-Week Low
$14.89$205.77
Typical Hold Time
0 Days89 Days
Enterprise Value
$3.48B$274.57B
Dividend Yield
—2.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edgewise Therapeutics Inc. Common Stock

No Aura AI signal available yet.

International Business Machines Corp

IBM trades at $227.88, up 0.38% with a bearish technical signal despite recent positive momentum. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, representing a 15.52% margin. Recent earnings beat expectations in two of the last three quarters, while Q3 2026 results are pending. Analyst consensus is mixed with 47% buy ratings and a $255.50 price target, suggesting 12% upside potential from current levels.

IBM presents a balanced opportunity with solid profitability and AI consulting growth offset by cyclical mainframe weakness and negative cash flow trends. The stock's current valuation at 20.5x P/E appears reasonable given the company's pivot to high-margin hybrid cloud and AI services. Key risks include execution challenges in the AI transition and competitive pressures in the consulting space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWTX
100% Buy0% Sell
Avg holding period · 0 Days
IBM
13% Buy87% Sell
Avg holding period · 89 Days

Top news

Latest headlines on both assets

About Edgewise Therapeutics Inc. Common Stock

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.

Read more on EWTX →

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM →